Skyscape Web Viewer : Yao & Artusio's Anesthesiology: Problem-Oriented Patient Management : Medication Index

View All
Minipress
Misoprostol
Mivacurium A.6. What are acetylcholinesterase and plasma cholinesterase? What is the clinical significance of heterozygosity for atypical pseudocholinesterase (PChE)? B.1. How is the choice of NMBA made? B.2. What factors can alter sensitivity to nondepolarizing NMBAs? B.6. How do we define adequate recovery of neuromuscular function? B.7. Are clinical tests of neuromuscular recovery reliable? C.5. How are nondepolarizing neuromuscular blockers affected by renal failure?
monoamine Oxidase Inhibitor A.12. What is neuroleptic malignant syndrome (NMS)? What is serotonin syndrome? A.8. What are some factors that can lower PChE levels? B.11. What is tramadol? Is it an opioid? B.16. What is meperidine? How is it different from other opioids? B.6. Are there any psychiatric medications he is taking that would impact your anesthetic care? D.6. What is the evidence regarding the efficacy and utility of perioperative gabapentinoids, intraoperative methadone, and subanesthetic ketamine in postoperative recovery as recommended in ERAS protocols?
Montelukast
Morphine
Motrin
Moxifloxacin
MS Contin
Muse
Mycophenolate A.7. What treatments are available for a patient with MG? A.9. How are immunosuppressive drugs managed in kidney transplant recipients? B.3. How are routine medications and immunosuppressive medications managed in the perioperative period? D.10. How would you manage this patient in the intensive care unit? D.2. What are immunosuppressive agents, and how do they affect anesthetic care? D.6. What immunosuppressive agents will be given after liver transplantation? What are the major side effects?
Mydriacyl
N-acetyl-p-aminophenol
Nadolol
Naloxone A.3. What are the mechanisms of acupuncture analgesia? B.10. How would you treat the side effects of opioid therapy? B.2. What are the considerations if a patient is taking buprenorphine for chronic pain versus medication treatment for opioid use disorder (OUD)? C.16. What is your approach to emergence? What if the patient does not regain consciousness? C.3. What are the specific considerations for anesthetic management and monitoring of the patient presenting for open TAAA repair? C.3. What is your analgesic plan? Perioperative Pain Management and Multimodal Pain Management
Naltrexone A.1. What are the risk factors for perioperative aspiration? B.14. What is the pharmacologic management of CRPS?
Nateglinide
Neostigmine
Neo-Synephrine
Nephron B.5. How would you measure creatinine clearance in this patient, and what is its value in this case? C.6. How would you maintain anesthesia during the case? D.4. If this patient had a crush injury and low urine output, what other concerns might you have? What if the patient has dark or "tea-colored" urine?
Neuromuscular Blocking Agents
Neurontin
Nicardipine
Nicotine A.4. The patient has a long history of cigarette smoking. What is the significance of this finding? What is the importance of the patient's current vaping habit? D.5. What components of ERAS are applied in the postoperative phase of the care of patients following CRS?
Nifedipine A.14. What is the mechanism of action of the major antihypertensive drugs? A.6. What is the usual obstetrical management for patients with breech presentation? A.6. Which perioperative medical therapies would you employ to reduce the incidence of myocardial ischemia? B.5. What are the goals and agents of choice for severe hypertension seen with preeclampsia? C.4. Is succinylcholine contraindicated in open-globe eye injuries? How does succinylcholine affect IOP? E.11. What are the significant implications of posttransplant hypertension?
Nimodipine A.7. What are the neuroprotective effects of administering magnesium (Mg)? C.2. How is open repair of thoracic aneurysms performed? D.7. What steps can be taken to prevent cerebral vasospasm? D.8. What treatments can be undertaken once a diagnosis of cerebral vasospasm is made?
Nitroglycerin
Nitroprusside
Nizatidine
Norepinephrine